Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 33Neoplasms 25Prostatic Neoplasms 16Colorectal Neoplasms 13Lung Neoplasms 11Multiple Myeloma 9Head and Neck Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Pancreatic Neoplasms 6Neoplasm Metastasis 6Urinary Bladder Neoplasms 5Hematologic Neoplasms 5Gastrointestinal Neoplasms 5Advanced Cancer 5Uterine Cervical Neoplasms 4Smoking Cessation 4Ovarian Neoplasms 4Melanoma 4Leukemia 4Colonic Neoplasms 4Anxiety Disorders 4Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Recurrence 3Rectal Neoplasms 3Neoplasms, Plasma Cell 3Motor Activity 3Lymphoma, Follicular 3Lymphedema 3

Interventions

Blood Specimen Collection 3veliparib 2Surveys and Questionnaires 2Counseling 2Carboplatin 2Zoledronic Acid 1Videotape Recording 1Telemedicine 1Taxes 1Tamoxifen 1Standard of Care 1Specimen Handling 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Letrozole 1Genotype 1Genetic Counseling 1Exercise Test 1Echocardiography 1Early Intervention, Educational 1Docetaxel 1Diet, Mediterranean 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hereditary Breast and Ovarian Cancer Syndrome × Standard of Care × Clear all
NCT06534424 2025-06-27

Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
152 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡